Artwork

เนื้อหาจัดทำโดย Myriad Genetics เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Myriad Genetics หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Player FM - แอป Podcast
ออฟไลน์ด้วยแอป Player FM !

The Modern Urologist

แบ่งปัน
 

Manage series 2902383
เนื้อหาจัดทำโดย Myriad Genetics เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Myriad Genetics หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal

Myriad Genetics brings you a casual, yet educational podcast about modern topics in Urology. Because every man with prostate cancer deserves a better answer.

  continue reading

51 ตอน

Artwork

The Modern Urologist

updated

iconแบ่งปัน
 
Manage series 2902383
เนื้อหาจัดทำโดย Myriad Genetics เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Myriad Genetics หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal

Myriad Genetics brings you a casual, yet educational podcast about modern topics in Urology. Because every man with prostate cancer deserves a better answer.

  continue reading

51 ตอน

Toate episoadele

×
 
Send us a text The Modern Urologist Podcast has launched a new miniseries, Precision Oncology and Prostate Cancer: The New Standard of Care, hosted by Dr. Paul Sieber and Ashleigh Renitsky, Oncology PA. This series will focus on the evolving role of genetic testing in prostate cancer care and its impact on personalized patient treatment plans. Episode #1 - Genetic testing basics The first installment will provide an overview of genetic testing, highlighting the difference between germline and somatic testing, and their implications for personalized treatment. This episode emphasizes the importance of integrating streamlined testing protocols into clinical practice, understanding test results to tailor therapies for patients, and leveraging genetic counselors.…
 
Send us a text In this conversation, Dr. Tim Richardson from Wichita Urology and Dr. Ben Lowentritt from Chesapeake Urology discuss the integration and utilization of Advanced Practice Providers (APPs) in urology practices, particularly within advanced prostate cancer (APC) clinics. Dr. Lowentritt explains the benefits of using APPs to address physician shortages, increase efficiency, and more.…
 
Send us a text Dr. Tim Richardson from Wichita Urology and Dr. Jonathan Henderson from Arkansas Urology discuss the use and benefits of Prolaris testing in prostate cancer management. Dr. Henderson elaborates on how Prolaris aids in decision-making for his prostate cancer patients, highlighting its role in reducing overtreatment and undertreatment.…
 
Send us a text Dr. Tim Richardson from Wichita Urology interviews Dr. Scott Sellinger, the current president - elect of the Large Urology Group Practice Association (LUGPA). They discuss LUGPA's history, current status, and future goals. Initially founded to support large independent urology practices, LUGPA now includes any independent urology practice. Dr. Sellinger also highlights the challenges facing independent urology practices. *Episode was filmed 11/23…
 
Send us a text In this episode of The Modern Urologist, Dr. Mark Edney is joined by Dr. Paul Sieber, a urologist from Lancaster, Pennsylvania, to discuss the use of genetic testing in the diagnosis and treatment of prostate cancer. Dr. Sieber emphasizes the importance of hereditary cancer testing, as well as tissue-based biomarkers like Prolaris®, in determining the best treatment plans for this prostate cancer patients.…
 
Send us a text On this episode of TMU we're diving deep into the rapidly evolving landscape of prostate cancer diagnosis and treatment with special guest, Dr. Adam Cole, a board-certified pathologist. Dr. Cole will discuss the traditional Gleason grading system, the limitations of pathology, and how incorporating genetic markers can improve patient outcomes.…
 
Send us a text In this episode of TMU we have the pleasure of being joined by two urology experts, Dr. Ravi Rajan, Urologist, and Dr. William Ding, Radiation Oncologist, as they discuss topics ranging from genetic testing in prostate cancer for personalized treatment plans to the importance of collaboration between urologists and radiation oncologists. Our guests highlight the significance of effective communication and seamless integration within the treatment team. They also shed light on the consequences of lack of collaboration and how it can impacts patient care and satisfaction. Listen along as they share valuable insights and practical tips for improving communication and collaboration between these specialties.…
 
Send us a text Join our panel of experts, Dr. Neal Shore, Dr. Ben Lowentritt, Dr. Ted Schaefer, and Dr. Jonathan Tward, as they discuss the various components and utility of a full workup for localized prostate cancer. They explore the importance of germline testing and how it has significant implications for personalized treatment choices. They will also discuss and examine the use of traditional biomarkers like PSA, PSA density, kinetics, and the Gleason grade system, as well as newer advancements in molecular markers and the potential use of artificial intelligence. Tune in as our experts share their insights, experiences, and expectations for the future of prostate cancer care.…
 
Send us a text On this episode of TMU, Dr. Mark Edney welcomes Dr. Deepak Kapoor as they dive into the world of private equity and healthcare policy. They discuss the opportunities and challenges faced by private practices in the field of Urology, and explore the topic of private equity with Dr. Kapoor's experiences as the chairman of Solaris Health. Listeners will gain insight into the differences between private equity and venture capital. Dr. Kapoor and Dr. Edney stress the importance of everyone having a voice in this thought-provoking conversation that highlights the ultimate goal of providing great patient care.…
 
Send us a text On this episode of TMU, we sit down with Ray Wezik, the Director of Policy and Advocacy for the American Urological Association (AUA), as we dive into the world of patient advocacy and lobbying. Ray shares his perspective as someone who works with over 75 patient advocacy organizations to leverage their voices and become better advocates together. We discuss the importance of collaboration between patient advocacy and medical professionals for effective efforts, and Ray shares insights on how networking events are bringing patients and urologists to state capitals to advocate for solutions and funding for research programs. Ray also shares valuable insights on working with regulatory agencies like CMS, and the value of determining CPT codes.…
 
Send us a text On this episode of TMU, we’re joined by Nilay Gandhi, Urologist at Potomac Urology in Northern Virginia, as he shares his personal story on why he chose to pursue urology and his involvement in patient advocacy. Dr. Gandhi also discusses how incorporating genetic testing into his practice has improved patient care. Lastly, we’ll cover the growing presence of advanced practice providers in urology and the need for personalized treatment options for prostate cancer patients. Tune in to learn more!…
 
Send us a text Dr. TJ Slavin, Chief Medical Officer of Myriad Genetics hosts this episode of the Modern Urologist joined by Dr. Angelo Baccala, at Lehigh Valley Health Network and Kara Cossis, PA-C, MPH, at Chesapeake Urology, to discuss genetic testing advancements in prostate cancer care to improve patient outcomes. Panelists' will dive into the rising rates of prostate cancer due to advanced diagnosis and how they have incorporated genetic testing into their practices. *This episode of The Modern Urologists was derived from an episode of Myriad Live, a recorded open-forum webinar hosted by Dr. Thomas Slavin. The opinions and views expressed in this recording do not necessarily represent those of Myriad Genetics or its affiliates.…
 
Send us a text In this episode of The Modern Urologist, we are joined by Dr. David Levy who has done extensive research on prostate cancer nutrition and treatment. Dr. Levy will discuss measures that can be taken to decrease risk of disease such as taking supplements and vitamins. In addition, he mentions which foods to incorporate in your diet and those to avoid to possibly prevent or delay prostate cancer progression.…
 
Send us a text In this episode, we continue our conversation with Shelby Moneer and Ali Manson with ZERO – The End of Prostate Cancer, as they discuss the education and research support ZERO provides. They will also talk through where they see the organization going.
 
Send us a text In the first of a two-part series, Shelby Moneer, VP of Patient Programs and Education and Ali Manson, VP of Government Relations at ZERO – The End of Prostate Cancer, join Dr. Todd Cohen to discuss their advocacy efforts to educate and support all men who are impacted by prostate cancer. They will discuss ZERO's health equity work to combat racial disparity, creating support groups for patients and their caregivers throughout the prostate cancer journey and nationwide fundraising opportunities.…
 
Loading …

ขอต้อนรับสู่ Player FM!

Player FM กำลังหาเว็บ

 

คู่มืออ้างอิงด่วน

ฟังรายการนี้ในขณะที่คุณสำรวจ
เล่น